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 The Challenges of Conducting 
Research in Developing Countries 
Sergio G. Litewka M.D., M.P.H. 
University of Miami Ethics Programs 
 
Washington University in St. Louis 
November 28th 2011 
Disclaimer 
• The views provided in these slides are solely 
the opinions of the presenter are not meant 
to represent any group or organization. 
 
Challenges of a multicultural 
environment 
 
• A working definition of research. What is 
perceived by the society as research 
– Production of valid, reliable, and generalizable 
knowledge (Knowledge is organized information) 
• Each community gives a special accent to the 
activity 
• Influence of the dominant paradigms 
Significant Concerns 
– Lack of mandatory training on research ethics and 
responsible conduct of research 
– Identification and management of conflicts of interest 
– Enforcement of current regulations. Normative 
polyphony 
– Research Ethics Committees ( quorum, competence, 
independence, informed consent process, logistics 
and infrastructure) 
– Weak or inexistent institutional accountability 






















Clinical Trials in Latin America 
January 1st 2005- April 1st 2011 
Source : Clinicaltrials.gov 
CLINICAL TRIALS TOTAL 
SPONSORED BY INDUSTRY 
Research misconduct and Human 
Subjects Protection 
• Research misconduct means fabrication, falsification, or plagiarism in 
proposing, performing, or reviewing research, or in reporting research 
results.  
 
(a) Fabrication is making up data or results and recording or reporting 
them. 
 
(b) Falsification is manipulating research materials, equipment, or 
processes, or changing or omitting data or results such that the research is 
not accurately represented in the research record. 
 
(c) Plagiarism is the appropriation of another person's ideas, processes, 
results, or words without giving appropriate credit. 
 
(d) Research misconduct does not include honest error or differences of opinion. 
 
• Office of Research Integrity, United States of America  
 
Other definitions 
• “All serious deviations from accepted ethical research 
practices in proposing, performing and reporting research” 
– Norwegian Council on Scientific Dishonesty 
• “Behavior by a researcher, intentional or not that falls short 
of good ethical and scientific standards” 
– Joint Consensus Conference on Misconduct in Biomedical 
Research . Consensus statement , Edinburgh, October 28 & 
29, 1999 
Research misconduct in Latin 
American countries 
• Magnitude and awareness  of the problem  
 ( is there a problem?) 
• Perception of scientific misconduct 
• Environmental factors 
– Scientist, policy makers and the society 
• Lack of communication between media and scientists 
• Scientist may be perceived as “closed communities” 
– Latin American researchers , in many cases are working for 
governments ( civil servants) working within a vertical and 
hierarchical system, not necessarily based in merits 
– Yriart M,Braginski R. The resurrection of the crotoxine case (1989-1996): 
Science, politics and media. Redes, Vol V,No 11;pp 113-139. National 
University of Quilmes, Argentina 
 
 
Cultural and logistical challenges in the 
Latin American and Caribbean scenario 
• Informed consent 
– Legal information may be excessive and confusing 
– Adequate disclosure of risks and eventual benefits 
– Risk of therapeutic misunderstanding 
• IRBs 
– Definition of exempt studies 
– Lack of resources 
– Clinical Ethics Committees acting as Research Ethics 
Committees  
– Conflicts of interests- IRB independence 
– Deficiencies in assuring privacy and confidentiality 




 Traditions and institutions by which authority in a country is exercised  
– Process by which governments are selected, monitored and replaced 
• Voice and accountability 
• Political stability and absence of terrorism/violence 
– Capacity of a government to effectively formulate and implement 
sound policies 
• Government effectiveness 
• Regulatory quality 
– Respect of the citizens and the state for the institutions that govern 
interactions among them 
• Rule of law 
• Control of corruption 
 
Kaufmann D, Kraay A, Mastruzzi M. Global Economy and Development. 
Brookings Institutions. September 2010 www.govindicators.org 




Research misconduct in a multicultural 
environment  
• Understanding  differences in what is 
perceived as research misconduct  
• Understanding that research misconduct 
might be embedded in other layers of 
misconduct, not necessarily linked to research 
activities 
• Fostering education 
• Promoting transparence 
 










Brasilia- Brazil. No 
current fellow 
SEPLAN Ministry of 
Health- Honduras 





Fe de Bogotá- 
Colombia 
Grant # 1R25TW008186 / Pan American Bioethics Initiative. 
Fogarty International Center (NIH-FIC) 
New  CITI Program modules by country 








Conclusions: Critical issues 
• Ethical standards, laws and regulations  
• Post trial access to benefits 
• Placebo use 
• Local capabilities 
• Definition of vulnerability 
 
 
